No correlation was found between ps-NA titers following the fourth dose and age, sex, comorbidities (diabetes mellitus, hypertension, dyslipidemia, and impaired renal function), or subtypes of immunosuppression treatment (MMF, mTOR, or prednisone). The gene discussed is MTOR; the disease is metabolic syndrome.